Your browser doesn't support javascript.
loading
Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma.
Behjati, Sam; Tarpey, Patrick S; Haase, Kerstin; Ye, Hongtao; Young, Matthew D; Alexandrov, Ludmil B; Farndon, Sarah J; Collord, Grace; Wedge, David C; Martincorena, Inigo; Cooke, Susanna L; Davies, Helen; Mifsud, William; Lidgren, Mathias; Martin, Sancha; Latimer, Calli; Maddison, Mark; Butler, Adam P; Teague, Jon W; Pillay, Nischalan; Shlien, Adam; McDermott, Ultan; Futreal, P Andrew; Baumhoer, Daniel; Zaikova, Olga; Bjerkehagen, Bodil; Myklebost, Ola; Amary, M Fernanda; Tirabosco, Roberto; Van Loo, Peter; Stratton, Michael R; Flanagan, Adrienne M; Campbell, Peter J.
Afiliação
  • Behjati S; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Tarpey PS; Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Haase K; Corpus Christi College, Cambridge CB2 1RH, UK.
  • Ye H; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Young MD; The Francis Crick Institute, London NW1 1AT, UK.
  • Alexandrov LB; Department of Histopathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex HA7 4LP, UK.
  • Farndon SJ; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Collord G; Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA.
  • Wedge DC; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Martincorena I; UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
  • Cooke SL; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Davies H; Oxford Big Data Institute and Oxford Centre for Cancer Gene Research, Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford OX3 7BN, UK.
  • Mifsud W; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Lidgren M; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Martin S; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Latimer C; UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
  • Maddison M; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Butler AP; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Teague JW; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Pillay N; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Shlien A; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • McDermott U; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Futreal PA; Department of Histopathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex HA7 4LP, UK.
  • Baumhoer D; University College London Cancer Institute, Huntley Street, London WC1E 6BT, UK.
  • Zaikova O; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8.
  • Bjerkehagen B; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Myklebost O; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Amary MF; Department of Genomic Medicine, MD Anderson Cancer Center, University of Texas, Houston, Texas 77030, USA.
  • Tirabosco R; Bone Tumour Reference Centre, Institute of Pathology, University Hospital Basel, University of Basel, Basel 4031, Switzerland.
  • Van Loo P; Oslo University Hospital, Oslo 0379, Norway.
  • Stratton MR; Oslo University Hospital, Oslo 0379, Norway.
  • Flanagan AM; Oslo University Hospital, Oslo 0379, Norway.
  • Campbell PJ; University of Bergen, Bergen 5020, Norway.
Nat Commun ; 8: 15936, 2017 06 23.
Article em En | MEDLINE | ID: mdl-28643781
ABSTRACT
Osteosarcoma is a primary malignancy of bone that affects children and adults. Here, we present the largest sequencing study of osteosarcoma to date, comprising 112 childhood and adult tumours encompassing all major histological subtypes. A key finding of our study is the identification of mutations in insulin-like growth factor (IGF) signalling genes in 8/112 (7%) of cases. We validate this observation using fluorescence in situ hybridization (FISH) in an additional 87 osteosarcomas, with IGF1 receptor (IGF1R) amplification observed in 14% of tumours. These findings may inform patient selection in future trials of IGF1R inhibitors in osteosarcoma. Analysing patterns of mutation, we identify distinct rearrangement profiles including a process characterized by chromothripsis and amplification. This process operates recurrently at discrete genomic regions and generates driver mutations. It may represent an age-independent mutational mechanism that contributes to the development of osteosarcoma in children and adults alike.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rearranjo Gênico / Osteossarcoma / Mutação Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rearranjo Gênico / Osteossarcoma / Mutação Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article